Jazz Pharmaceuticals plc (J7Z) — Cash Flow Reinvestment Rate
Jazz Pharmaceuticals plc (J7Z) has a Cash Flow Reinvestment Rate of 0.59x as of March 2026, reinvesting €239.70 Million (capex €19.70 Million plus investments €220.00 Million) from operating cash flow of €408.20 Million. Explore Jazz Pharmaceuticals plc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jazz Pharmaceuticals plc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Jazz Pharmaceuticals plc across 13 annual periods. Also explore total assets of Jazz Pharmaceuticals plc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year capital reinvestment analysis for Jazz Pharmaceuticals plc. For live market cap and broader valuation context, see Jazz Pharmaceuticals plc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €680.03 Million | €1.36 Billion | €209.75 Million | ▲ +37.8% |
| 2024 | 0.36x | €508.19 Million | €1.40 Billion | €48.07 Million | ▲ +143.8% |
| 2023 | 0.15x | €163.06 Million | €1.09 Billion | €42.96 Million | ▲ +531.4% |
| 2022 | 0.02x | €30.08 Million | €1.27 Billion | €29.05 Million | ▼ -98.3% |
| 2021 | 1.41x | €1.10 Billion | €778.51 Million | €27.64 Million | ▲ +92.5% |
| 2020 | 0.73x | €657.68 Million | €899.65 Million | €15.00 Million | ▲ +425.4% |
| 2019 | 0.14x | €108.03 Million | €776.40 Million | €40.13 Million | ▼ -66.4% |
| 2018 | 0.41x | €331.29 Million | €798.90 Million | €20.37 Million | ▲ +56.2% |
| 2017 | 0.27x | €183.95 Million | €693.09 Million | €28.95 Million | ▼ -91.9% |
| 2016 | 3.26x | €1.93 Billion | €592.39 Million | €181.58 Million | ▲ +1612.7% |
| 2015 | 0.19x | €101.23 Million | €531.94 Million | €35.96 Million | ▼ -23.7% |
| 2014 | 0.25x | €101.62 Million | €407.61 Million | €36.35 Million | ▼ -4.4% |
| 2013 | 0.26x | €75.25 Million | €288.43 Million | €9.98 Million | — |